BNP Paribas Financial Markets’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $74.7K | Buy |
|
|||||
|
2025
Q2 | $45.2K | Sell |
|
|||||
|
2025
Q1 | $51.7K | Sell |
|
|||||
|
2024
Q4 | $679K | Sell |
|
|||||
|
2024
Q3 | $1.13M | Sell |
|
|||||
|
2024
Q2 | $1.38M | Sell |
|
|||||
|
2024
Q1 | $4.38M | Buy |
|
|||||
|
2023
Q4 | $5.72M | Buy |
|
|||||
|
2023
Q3 | $4.84M | Buy |
|
|||||
|
2023
Q2 | $7.17M | Buy |
|
|||||
|
2023
Q1 | $1.26M | Buy |
|
|||||
|
2022
Q4 | $387K | Sell |
|
|||||
|
2022
Q3 | $574K | Buy |
|
|||||
|
2022
Q2 | $325K | Buy |
|
|||||
|
2022
Q1 | $442K | Sell |
|
|||||
|
2021
Q4 | $1.68M | Sell |
|
|||||
|
2021
Q3 | $2.23M | Buy |
|
|||||
|
2021
Q2 | $683K | Sell |
|
|||||
|
2021
Q1 | $1.44M | Buy |
|
|||||
|
2020
Q4 | $874K | Sell |
|
|||||
|
2020
Q3 | $383K | Buy |
|
|||||
|
2020
Q2 | $18.4K | Sell |
|
|||||
|
2020
Q1 | $147K | Sell |
|
|||||
|
2019
Q4 | $3.68M | Buy |
|
|||||
|
2019
Q3 | $115K | Sell |
|
|||||
|
2019
Q2 | $5.7M | Buy |
|
|||||
|
2019
Q1 | $255K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $29.1K | Buy |
|
|||||
|
2018
Q2 | $15.1K | Sell |
|
|||||
|
2018
Q1 | $58K | Buy |
|
|||||
|
2017
Q4 | $58.7K | Buy |
|
|||||
|
2017
Q3 | $44.3K | Sell |
|
|||||
|
2017
Q2 | $32.2K | Buy |
|
|||||
|
2017
Q1 | $2.64K | Sell |
|
|||||
|
2016
Q4 | $5.3K | Sell |
|
|||||
|
2016
Q3 | $49.7K | Buy |
|
|||||
|
2016
Q2 | $20.8K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $151K | Sell |
|
|||||
|
2015
Q3 | $47.2K | Buy |
|
|||||
|
2015
Q2 | $29K | Buy |
|
|||||
|
2015
Q1 | $7.91K | Buy |
|
|||||
|
2014
Q4 | $8 | Sell |
|
|||||
|
2014
Q3 | $18.6K | Buy |
|
|||||
|
2014
Q2 | $865 | Buy |
|
|||||
|
2014
Q1 | $4 | Sell |
|
|||||
|
2013
Q4 | $3.25K | Sell |
|
|||||
|
2013
Q3 | $979K | Sell |
|
|||||
|
2013
Q2 | $465K | Buy |
|